Vertex has announced plans for recent expansion to support the company's recent growth and further research into cell and genetic therapy. Vertex has also dedicated a site to Jeffrey Leiden, called the Jeffrey Leiden Center for Cell and Genetic Therapies I.
As the new chairman of Vertex, Jeffrey Leiden aims to help the local community by supplying employment for those who lost their jobs during the COVID-19 pandemic.
Jeffrey Leiden, M.D., Ph.D., Executive Chairman of Vertex Pharmaceuticals, is honored with a Lifetime Achievement in BioPharma Award during the Forbes Healthcare Summit.
Jeffrey Leiden, M.D., Ph.D., Executive Chairman of Vertex Pharmaceuticals, is "an amazing mix of genius, leadership and compassion," says Vertex board member, Bruce Sachs.
"In facing the crisis, we were determined to evaluate, act, and communicate based on science, data, and thoughtful policy approaches, not gut reactions nor what people wanted to hear or what others were saying. It’s these factors, as well as our deeply rooted empathy for those who are at particular risk from the virus, that drove our decisions at Vertex; this is what has helped us keep each other, and the patients we serve, safe."